Left Bundle Branch Area Pacing Using Conventional Stylet-driven Pacemaker Leads for Cardiac Resynchronization Therapy
LeCaRT
1 other identifier
interventional
170
1 country
11
Brief Summary
The aim of this study proposal is to compare the effectiveness of two distinct pacing modalities for cardiac resynchronization therapy. Our primary hypothesis is that left bundle branch area pacing (LBBAP) using conventional stylet driven pacemaker leads is an effective resynchronization method that yield to at least similar clinical benefits and outcomes when compare to biventricular pacing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2022
Longer than P75 for not_applicable
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2022
CompletedFirst Posted
Study publicly available on registry
May 9, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2028
ExpectedSeptember 23, 2024
September 1, 2024
3.1 years
April 29, 2022
September 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of days elapsed from study procedure to first occurrence of one of the following events (combined endpoint) or to study close-out in the total patient population.
First occurrence of one of the following clinical events: death, hospitalization or unscheduled visit for heart failure (HF) or worsening HF symptoms with adaptation of the medical therapy, implant failure for any cause, implantable electronic cardiac device (IECD) re-intervention for any reason during follow-up (Lead Dislocation/phrenic nerve stimulation…)
12 months
Secondary Outcomes (5)
Improvement of procedural characteristics: Operative and fluoroscopic times
1 day
Correction of electrical desynchrony post-implant
1/6/12 months
Clinical functional response (6MWT)
6 months
Left ventricular reverse remodelling
6/12 months
Implantable cardioverter defibrillator (ICD) therapies
6/12 months
Study Arms (2)
LBBAP
EXPERIMENTALBiV
ACTIVE COMPARATORInterventions
Left bundle branch area pacing using conventional stylet driven pacemaker leads for cardiac resynchronization therapy
Cardiac resynchronization therapy (CRT) using biventricular pacing (BiV)
Eligibility Criteria
You may qualify if:
- Aged 18 or above
- Left Ventricular Ejection Fraction (LVEF) and NYHA meeting one off the previous indications documented with transthoracic echocardiography (TTE) no later than 3 months before randomization.
- New York Heart Association (NYHA) class II-IV
- Baseline left bundle branch block and QRS \>130ms or QRS \>150ms of any morphology or a wide paced QRS duration.
You may not qualify if:
- Younger than 18 years old
- Pregnancy
- Any unstable medical condition, life expectancy \< 12 months
- Inability to provide consent or to undergo follow-up
- Narrow QRS duration (≤130ms) or prolonged QRS duration with typical Right Bundle Branch Block (RBBB) morphology on 12 lead ECG and sinus rhythm.
- Significant hypertrophic cardiomyopathy - any septum abnormality contra-indicating LBBAP implantation (according to physician's evaluation)
- Patients who are unable to perform a 6 minute walk test (6MWT) Note: patients should be able to perform a 6 minute walk test, but it is not a requirement to have the test performed before the procedure (e.g. due to inability of planning).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AZ Sint-Jan AVlead
Study Sites (11)
UZA
Edegem, Antwerpen, 2650, Belgium
CHU Charleroi
Lodelinsart, Henegouwen, 6042, Belgium
Jessa Ziekenhuis Hasselt
Hasselt, Limburg, 3500, Belgium
CHR Citadelle Liège
Liège, Liège, 4000, Belgium
UZ Gent
Ghent, Oost-Vlaanderen, 9000, Belgium
UZ Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
UCL Saint-Luc
Woluwe-Saint-Lambert, Vlaams-Brabant, 1200, Belgium
Clinique Saint-Pierre Ottignies
Ottignies-Louvain-la-Neuve, Waals-Brabant, 1340, Belgium
AZ Sint-Jan Brugge
Bruges, West-Vlaanderen, 8000, Belgium
AZ Delta
Roeselare, West-Vlaanderen, 8800, Belgium
CHU HELORA - Site Jolimont
Haine-Saint-Paul, 7100, Belgium
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Benoît le Polain de Waroux, MD, PhD
AZ Sint Jan Brugge AV
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Coordinating Principal Investigator
Study Record Dates
First Submitted
April 29, 2022
First Posted
May 9, 2022
Study Start
September 1, 2022
Primary Completion
September 30, 2025
Study Completion (Estimated)
September 30, 2028
Last Updated
September 23, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share